FDA Chief: Agency willing to approve COVID vaccine before the trial ends


(CNN NEWSOURCE) – The Food and Drug Administration could authorize emergency use of a COVID-19 vaccine before Phase Three trials are over, according to the Financial Times.

The Financial Times interviewed FDA Commissioner Dr. Stephen Hahn, who said if a vaccine developer applies for approval before the end of Phase Three, the FDA could authorize it.

Hahn said the agency would have to determine that the benefit outweighs the risk.

He also said the vaccine decision would be based on data, not politics.

Some doctors have expressed concern that just before election day President Trump might pressure the FDA to approve a coronavirus vaccine before it’s ready.

Copyright 2021 Nexstar Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

High School Standouts
Ask the Expert
Find A Job
wspa news app free for download choose your store below
download the wspa news app from the apple app store
download the wspa news app from the google play store